PUBLICATIONS
Lab of Molecular Pathology and Theranostics
> PUBLICATIONS > Publications
Integrin β3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in ALK-Rearranged NSCLC
성민정
2021-01-25
조회수 120
제목: Integrin β3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in ALK-Rearranged NSCLC
저널: Clinical Cancer Research
연권호: 2018 Sep 1;24(17):4162-4174. doi: 10.1158/1078-0432.CCR-17-3492.
Lab of Molecular Pathology and Theranostics / SAIHST, Sungkyunkwan University
Cancer center B4, Samsung Medical Center, 81 Irwon-ro, Gangnam-gu, Seoul 06351 TEL : +82-2-2148-7337Copyright © CGMP. All rights reserved.
